Skip to main content
. 2014 Jan;66(1):334–395. doi: 10.1124/pr.112.007336

Fig. 15.

Fig. 15.

(A) Chemical structure of SKLB1002. (B) SKLB1002 is docked into the active site of VEGFR2, showing interactions between SKLB1002 and VEGFR2 by using the in silico model. (C) A 2D interaction map of SKLB1002 and VEGFR2. Adapted from Zhang et al. (2011).